NYSE:RMD - ResMed Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $101.24 +1.14 (+1.14 %) (As of 02/22/2019 04:00 PM ET)Previous Close$100.10Today's Range$100.08 - $101.4652-Week Range$90.64 - $118.50Volume604,000 shsAverage Volume1.30 million shsMarket Capitalization$14.51 billionP/E Ratio28.68Dividend Yield1.48%Beta0.54 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings ResMed (NYSE:RMD) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.9 Wall Street analysts have issued ratings and price targets for ResMed in the last 12 months. Their average twelve-month price target is $109.80, suggesting that the stock has a possible upside of 8.46%. The high price target for RMD is $120.00 and the low price target for RMD is $99.60. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.222.302.222.00Ratings Breakdown: 1 Sell Rating(s)5 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)5 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)5 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)3 Sell Rating(s)5 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $109.80$127.00$109.00$68.80Price Target Upside: 8.46% upside8.11% upside6.03% upside33.58% downsideResMed (NYSE:RMD) Consensus Price Target History ResMed (NYSE:RMD) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails1/28/2019BMO Capital MarketsLower Price TargetOutperform ➝ Positive$120.00High1/25/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$99.60High1/25/2019Goldman Sachs GroupDowngradeBuy ➝ NeutralHigh1/23/2019Deutsche BankDowngradeBuy ➝ HoldLow10/26/2018Credit Suisse GroupUpgradeNeutral ➝ OutperformHigh4/24/2018UBS GroupDowngradeBuy ➝ NeutralMedium4/16/2018William BlairReiterated RatingOutperformLow4/4/2018CitigroupDowngradeBuy ➝ NeutralMedium3/7/2018Needham & Company LLCReiterated RatingHoldMedium1/23/2018Northland SecuritiesUpgradeUnder Perform ➝ Market PerformHigh1/23/2018MacquarieDowngradeNeutral ➝ SellHigh10/27/2017BarclaysBoost Price TargetUnderweight$68.00 ➝ $70.00N/A10/12/2017Jefferies Financial GroupReiterated RatingSell$56.00N/A8/2/2017Bank of AmericaDowngradeBuy ➝ NeutralHigh(Data available from 2/22/2017 forward) This page was last updated on 2/22/2019 by MarketBeat.com StaffFeatured Article: What strategies should day traders use to execute a trade?